Minimally invasive versus open liver resections for hepatocellular carcinoma in patients with metabolic syndrome Journal Article
| Authors: | Berardi, G.; Ivanics, T.; Sapisochin, G.; Ratti, F.; Sposito, C.; Nebbia, M.; D'Souza, D. M.; Pascual, F.; Tohme, S.; D'Amico, F. E.; Alessandris, R.; Panetta, V.; Simonelli, I.; Del Basso, C.; Russolillo, N.; Fiorentini, G.; Serenari, M.; Rotellar, F.; Zimitti, G.; Famularo, S.; Hoffman, D.; Onkendi, E.; Lopez-Ben, S.; Caula, C.; Rompianesi, G.; Chopra, A.; Abu Hilal, M.; Torzilli, G.; Corvera, C.; Alseidi, A.; Helton, S.; Troisi, R. I.; Simo, K.; Conrad, C.; Cescon, M.; Cleary, S.; Kwon, C. H. D.; Ferrero, A.; Ettorre, G. M.; Cillo, U.; Geller, D.; Cherqui, D.; Serrano, P. E.; Ferrone, C.; Mazzaferro, V.; Aldrighetti, L.; Kingham, T. P. |
| Article Title: | Minimally invasive versus open liver resections for hepatocellular carcinoma in patients with metabolic syndrome |
| Abstract: | OBJECTIVE: To compare minimally invasive (MILR) and open liver resections (OLRs) for hepatocellular carcinoma (HCC) in patients with metabolic syndrome (MS). BACKGROUND: Liver resections for HCC on MS are associated with high perioperative morbidity and mortality. No data on the minimally invasive approach in this setting exist. MATERIAL AND METHODS: A multicenter study involving 24 institutions was conducted. Propensity scores were calculated, and inverse probability weighting was used to weight comparisons. Short-term and long-term outcomes were investigated. RESULTS: A total of 996 patients were included: 580 in OLR and 416 in MILR. After weighing, groups were well matched. Blood loss was similar between groups (OLR 275.9±3.1 vs MILR 226±4.0, P =0.146). There were no significant differences in 90-day morbidity (38.9% vs 31.9% OLRs and MILRs, P =0.08) and mortality (2.4% vs 2.2% OLRs and MILRs, P =0.84). MILRs were associated with lower rates of major complications (9.3% vs 15.3%, P =0.015), posthepatectomy liver failure (0.6% vs 4.3%, P =0.008), and bile leaks (2.2% vs 6.4%, P =0.003); ascites was significantly lower at postoperative day 1 (2.7% vs 8.1%, P =0.002) and day 3 (3.1% vs 11.4%, P <0.001); hospital stay was significantly shorter (5.8±1.9 vs 7.5±1.7, P <0.001). There was no significant difference in overall survival and disease-free survival. CONCLUSIONS: MILR for HCC on MS is associated with equivalent perioperative and oncological outcomes to OLRs. Fewer major complications, posthepatectomy liver failures, ascites, and bile leaks can be obtained, with a shorter hospital stay. The combination of lower short-term severe morbidity and equivalent oncologic outcomes favor MILR for MS when feasible. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. |
| Journal Title: | Annals of Surgery |
| Volume: | 278 |
| Issue: | 5 |
| ISSN: | 0003-4932 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-11-01 |
| Start Page: | e1041 |
| End Page: | e1047 |
| Language: | English |
| DOI: | 10.1097/sla.0000000000005861 |
| PUBMED: | 36994755 |
| PROVIDER: | scopus |
| PMCID: | PMC11218006 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work